Presenilin-1 polymorphism and Alzheimer's disease
Higuchi, S.; Muramatsu, T.; Matsushita, S.; Arai, H.; Sasaki, H.
Lancet 347(9009): 1186
1996
ISSN/ISBN: 0140-6736 PMID: 8609783 Document Number: 467942
Document emailed within 1 workday
Related Documents
Cui, T.; Zhou, X.; Jin, W.; Zheng, F.; Cao, X. 2000: Gene polymorphism in apolipoprotein e and presenilin-1 in patients with late-onset Alzheimer's disease Chinese Medical Journal 113(4): 340-344Tabira, T. 1997: Molecular genetics of Alzheimer's disease--presenilin and other genes Rinsho Shinkeigaku 37(12): 1095-1096
Katayama, T.; Manabe, T.; Tohyama, M. 2003: Recent progress in 'HMGA1a' which causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(4): 677-688
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Wang, J.-t.; Li, L.; Yuan, J.; Zhang, Z.-x. 2013: Correlation between Apolipoprotein e polymorphism and age at onset of Alzheimer's disease in a Chinese Han population Zhonghua Yi Xue Za Zhi 93(3): 182-186
Jiang, S.; Lin, S.; Tang, G. 1999: The association between microsatellite polymorphism of alpha 1-antichymotrypsin gene and Alzheimer's disease Zhonghua Yi Xue Za Zhi 79(8): 610-612
He, X-ming.; Zhang, Z-xin.; Zhang, J-wu.; Zhou, Y-tao.; Tang, M-ni.; Wu, C-bin.; Hong, Z. 2006: Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population Chinese Medical Journal 119(14): 1204-1209
Peacock, M.L.; Warren, J.T.; Roses, A.D.; Fink, J.K. 1993: Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease Neurology 43(6): 1254-1256
Lai, S.; Chen, Y.; Wen, Z. 2001: Association between apolipoprotein E polymorphism and Alzheimer's disease: A population-based study in Guangzhou, China Zhonghua Liu Xing Bing Xue Za Zhi 22(3): 202-204
McCusker, S.M.; Curran, M.D.; Dynan, K.B.; McCullagh, C.D.; Urquhart, D.D.; Middleton, D.; Patterson, C.C.; McIlroy, S.P.; Passmore, A.P. 2001: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study Lancet 357(9254): 436-439
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292
Ng, H.K. 1994: Alzheimer's disease and Alzheimer-type of cerebral degenerations in Chinese Clinical and Experimental Neurology 31: 85-98
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299